155 related articles for article (PubMed ID: 14518720)
1. Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.
Mancini N; Canducci F; Carletti S; Berardinelli E; Serafini G; Grieco A; Perotti M; Malcangi G; Danieli MG; Varaldo PE; Clementi M; Burioni R
J Biol Regul Homeost Agents; 2003; 17(2):183-7. PubMed ID: 14518720
[TBL] [Abstract][Full Text] [Related]
2. Nonneutralizing human antibody fragments against hepatitis C virus E2 glycoprotein modulate neutralization of binding activity of human recombinant Fabs.
Burioni R; Bugli F; Mancini N; Rosa D; Di Campli C; Moroncini G; Manzin A; Abrignani S; Varaldo PE; Clementi M; Fadda G
Virology; 2001 Sep; 288(1):29-35. PubMed ID: 11543655
[TBL] [Abstract][Full Text] [Related]
3. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment.
Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R
J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283
[TBL] [Abstract][Full Text] [Related]
4. Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.
Burioni R; Mancini N; Carletti S; Perotti M; Grieco A; Canducci F; Varaldo PE; Clementi M
Virology; 2004 Oct; 327(2):242-8. PubMed ID: 15351212
[TBL] [Abstract][Full Text] [Related]
5. Detection of antibody to hepatitis C virus E2 recombinant antigen among samples indeterminate for anti-HCV after wide serological testing and correlation with viremia. The Spanish Study Group for Blood Donors at Risk of Transmission of HCV.
León P; López JA; Elola C; Domingo CJ; Echevarria JM
Vox Sang; 1996; 70(4):213-6. PubMed ID: 9123926
[TBL] [Abstract][Full Text] [Related]
6. Cross-reactivity and clinical impact of the antibody response to hepatitis C virus second envelope glycoprotein (E2).
Hadlock KG; Gish R; Rowe J; Rajyaguru SS; Newsom M; Warford A; Foung SK
J Med Virol; 2001 Sep; 65(1):23-9. PubMed ID: 11505439
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus infection in dialysis and chronic liver patients: Viraemia dependent anti-E2-antibody response.
Hanuka N; Sikuler E; Tovbin D; Neville L; Nussbaum O; Mostoslavsky M; Orgel M; Yaari A; Manor S; Dagan S; Hilzenrat N; Shemer-Avni Y
J Med Virol; 2004 Aug; 73(4):529-35. PubMed ID: 15221896
[TBL] [Abstract][Full Text] [Related]
8. Neutralization activity and kinetics of two broad-range human monoclonal IgG1 derived from recombinant Fab fragments and directed against Hepatitis C virus E2 glycoprotein.
Diotti RA; Sautto GA; Solforosi L; Mancini N; Clementi M; Burioni R
New Microbiol; 2012 Oct; 35(4):475-9. PubMed ID: 23109015
[TBL] [Abstract][Full Text] [Related]
9. Characterization and mapping of a B-cell immunogenic domain in hepatitis C virus E2 glycoprotein using a yeast peptide library.
Mink MA; Benichou S; Madaule P; Tiollais P; Prince AM; Inchauspe G
Virology; 1994 Apr; 200(1):246-55. PubMed ID: 7510436
[TBL] [Abstract][Full Text] [Related]
10. Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments.
Burioni R; Plaisant P; Manzin A; Rosa D; Delli Carri V; Bugli F; Solforosi L; Abrignani S; Varaldo PE; Fadda G; Clementi M
Hepatology; 1998 Sep; 28(3):810-4. PubMed ID: 9731577
[TBL] [Abstract][Full Text] [Related]
11. Humoral immune response against hepatitis C virus.
Burioni R; Mancini N; Canducci F; Carletti S; Grieco A; Perotti M; Serafini G; Berardinelli E; Bighi S; Varaldo PE; Clementi M
J Biol Regul Homeost Agents; 2003; 17(2):125-7. PubMed ID: 14518709
[TBL] [Abstract][Full Text] [Related]
12. Murine antibodies against E2 and hypervariable region 1 cross-reactively capture hepatitis C virus.
Esumi M; Ahmed M; Zhou YH; Takahashi H; Shikata T
Virology; 1998 Nov; 251(1):158-64. PubMed ID: 9813211
[TBL] [Abstract][Full Text] [Related]
13. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
14. Conformational epitopes detected by cross-reactive antibodies to envelope 2 glycoprotein of the hepatitis C virus.
Nakano I; Fukuda Y; Katano Y; Hayakawa T
J Infect Dis; 1999 Oct; 180(4):1328-33. PubMed ID: 10479166
[TBL] [Abstract][Full Text] [Related]
15. Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins.
da Silva Cardoso M; Siemoneit K; Sturm D; Krone C; Moradpour D; Kubanek B
J Med Virol; 1998 May; 55(1):28-34. PubMed ID: 9580883
[TBL] [Abstract][Full Text] [Related]
16. Expression, purification and immunogenic characterization of hepatitis C virus recombinant E1E2 protein expressed by Pichia pastoris yeast.
Cai W; Su L; Liao Q; Ye L; Wu Y; Wu Z; She Y
Antiviral Res; 2010 Oct; 88(1):80-5. PubMed ID: 20691736
[TBL] [Abstract][Full Text] [Related]
17. Association of antibodies to hepatitis C virus glycoproteins 1 and 2 (anti-E1E2) with HCV disease.
Hamed MR; Tarr AW; McClure CP; Ball JK; Hickling TP; Irving WL
J Viral Hepat; 2008 May; 15(5):339-45. PubMed ID: 18221305
[TBL] [Abstract][Full Text] [Related]
18. Human monoclonal antibodies that react with the E2 glycoprotein of hepatitis C virus and possess neutralizing activity.
Schofield DJ; Bartosch B; Shimizu YK; Allander T; Alter HJ; Emerson SU; Cosset FL; Purcell RH
Hepatology; 2005 Nov; 42(5):1055-62. PubMed ID: 16250048
[TBL] [Abstract][Full Text] [Related]
19. Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries.
Bugli F; Mancini N; Kang CY; Di Campli C; Grieco A; Manzin A; Gabrielli A; Gasbarrini A; Fadda G; Varaldo PE; Clementi M; Burioni R
J Virol; 2001 Oct; 75(20):9986-90. PubMed ID: 11559832
[TBL] [Abstract][Full Text] [Related]
20. Predominance of antibodies to hepatitis C virus envelope proteins in various disease statuses of hepatitis C.
PodurI CD; Khanna A; Khundmiri SJ; Khaja MN; Kumar KS; Sugunan VS; Habibullah CM; Das MR
Acta Virol; 2001 Feb; 45(1):1-6. PubMed ID: 11394572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
